0001209191-20-004378.txt : 20200121 0001209191-20-004378.hdr.sgml : 20200121 20200121205811 ACCESSION NUMBER: 0001209191-20-004378 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200116 FILED AS OF DATE: 20200121 DATE AS OF CHANGE: 20200121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wang Theodore T CENTRAL INDEX KEY: 0001694061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 20537437 MAIL ADDRESS: STREET 1: C/O PUISSANCE CAPITAL MANAGEMENT LP STREET 2: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Cross-Border Opportunities II LLC CENTRAL INDEX KEY: 0001717781 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 20537438 BUSINESS ADDRESS: STREET 1: C/O PUISSANCE CAPITAL FUND (GP) LLC STREET 2: 950 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 878-3702 MAIL ADDRESS: STREET 1: C/O PUISSANCE CAPITAL FUND (GP) LLC STREET 2: 950 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Capital Fund (GP) LLC CENTRAL INDEX KEY: 0001695347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 20537439 BUSINESS ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-878-3700 MAIL ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Capital Management LP CENTRAL INDEX KEY: 0001658437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 20537440 BUSINESS ADDRESS: STREET 1: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-878-3700 MAIL ADDRESS: STREET 1: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puissance Capital Management (GP) LLC CENTRAL INDEX KEY: 0001695339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 20537441 BUSINESS ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-878-3700 MAIL ADDRESS: STREET 1: 950 THIRD AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-16 0 0001549084 EKSO BIONICS HOLDINGS, INC. EKSO 0001694061 Wang Theodore T C/O EKSO BIONICS HOLDINGS, INC. 1414 HARBOUR WAY SOUTH, SUITE 1201 RICHMOND CA 94804 1 0 1 0 0001717781 Puissance Cross-Border Opportunities II LLC C/O PUISSANCE CAPITAL FUND (GP) LLC 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 0 0 1 0 0001695347 Puissance Capital Fund (GP) LLC 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022 0 0 1 0 0001658437 Puissance Capital Management LP 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022 0 0 1 0 0001695339 Puissance Capital Management (GP) LLC 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022 0 0 1 0 Common Stock 2020-01-16 4 A 0 19445 0.45 A 38624 D Common Stock 20534898 I By Puissance Cross-Border Opportunities II LLC Stock Option (right to buy) 0.38 2020-01-16 4 A 0 136496 0.00 A 2030-01-16 Common Stock 136496 136496 D These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019. /s/ Theodore T. Wang 2020-01-19 Puissance Cross-Border Opportunities II LLC, By: Puissance Capital Fund (GP) LLC, its general partner, By: Theodore T. Wang, Managing Member 2020-01-19 Puissance Capital Fund (GP) LLC, By: Theodore T. Wang, Managing Member 2020-01-19 Puissance Capital Management LP, By: Puissance Capital Management (GP) LLC, its general partner, By: Theodore T. Wang, Managing Member 2020-01-19 Puissance Capital Management (GP) LLC, By: Theodore Wang, Managing Member 2020-01-19 EX-24 2 attachment1.htm EX-24 DOCUMENT
Exhibit 24
POWER OF ATTORNEY
(For Executing Forms 3, 4 and 5 and Schedule 13D)

       Know all by these presents, that the undersigned hereby constitutes and
appoints each of Jack Peurach, Jack Glenn and Jerome Wong of Ekso Bionics
Holdings, Inc. (the "Company"), or either of them signing singly, and with the
full power of substitution, the undersigned's true and lawful attorney-in-fact
to:
       (1) Prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC")
Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in
connection therewith, and any other documents necessary or appropriate to enable
the undersigned to make electronic filings with the SEC of reports required by)
in accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") or any rule or regulation of the SEC in the
undersigned's capacity as an officer, director or beneficial owner of more than
10% of a registered class of securities of the Company;
       (2) Prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the SEC Schedule 13D or Schedule 13G (including amendments
thereto and joint filing agreements in connection therewith) in accordance with
Sections 13(d) and 13(g) of the Exchange Act and the rules thereunder in the
undersigned's capacity as beneficial owner of more than 5% of a registered class
of securities of the Company;
       (3) Do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any of such Forms 3,
4 or 5 and Schedules 13D or 13G (including amendments thereto and joint filing
agreements in connection therewith) and timely file such forms or schedules with
the SEC and any stock exchange, self-regulatory association or any similar
authority; and
       (4) Take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact in serving in such capacity at the request of the
undersigned, are not assuming (nor is the Company assuming) any of the
undersigned's responsibilities to comply with Sections 13 or 16 of the Exchange
Act.
       This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 or Schedules 13D or 13G with respect to the undersigned's holdings of
and transactions in securities issued by the Company, (b) revocation by the
undersigned in a signed writing delivered to the Company and the foregoing
attorneys-in-fact or (c) as to any attorney-in-fact individually, until such
attorney-in-fact is no longer employed by the Company or Morrison & Foerster
LLP, as applicable.
       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of the date written below.
Date: January 19, 2020

By:
/s/ Theodore T. Wang


Name:	Theodore T. Wang
Title:	Director


ny-1850402